Alzheimer’s Disease – Page 3 – Waisman Center – UW–Madison

Cognitive and functional performance and plasma biomarkers of early Alzheimer’s disease in Down syndrome

Alzheimer’s polygenic risk scores are associated with cognitive phenotypes in Down syndrome

Characterizing the emergence of amyloid and tau burden in Down syndrome

Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer’s disease

AT(N) biomarker profiles and Alzheimer’s disease symptomology in Down syndrome

Weight Loss and Alzheimer’s Disease in Down Syndrome

Timing of Alzheimer’s Disease by Intellectual Disability Level in Down Syndrome

A Function of Amyloid-β in Mediating Activity-Dependent Axon/Synapse Competition May Unify Its Roles in Brain Physiology and Pathology

Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer’s disease: a cross-sectional study

Associations between diffusion MRI microstructure and cerebrospinal fluid markers of Alzheimer’s disease pathology and neurodegeneration along the Alzheimer’s disease continuum